Applications of 4-Amino-3,5-Diiodobenzoic Acid in Industrial Manufacturing

4-Amino-3,5-Diiodobenzoic Acid is a high-purity specialty aromatic compound featuring dual iodine atoms and amino functionality. Our manufacturing grade consistently serves key chemical synthesis sectors that demand traceability, precisely defined impurity profiles, and compliance with specialized process protocols. Below are several major downstream segments utilizing this intermediate under strict technical and regulatory regimens.

1. Contrast Agent Intermediate Manufacturing for Medical Imaging

Major global producers of X-ray and CT contrast agents use this material as a central iodinated intermediate. The regulated pathway requires exacting purity levels for safe downstream human use. Typical synthesis processes involve acylation or amide coupling reactions, incorporating the compound to introduce diiodinated aromatic structure, supporting radiopacity in the final pharmaceutical product.

Industry compliance standards

• ICH Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients)
• USP–NF Monographs for iodinated contrast agents
• EU GMP Annex 13 – APIs for Medicinal Products
• Japanese Pharmacopoeia General Notices (JP)

Typical usage ratio

• Stoichiometric ratios range from 0.8 to 1.2 molar equivalents, depending on synthetic route
• Adjustment based on target compound; may vary ±10% to optimize yield

Downstream process integration

• Incorporated at the halogenation or coupling step of contrast agent building block synthesis
• Purification and re-crystallization follow before onward reaction with radiopaque moieties
• Final step includes sulfonation or amidation within medical imaging API process
• Strict in-process testing for residual solvents and trace impurities

Final product types

• Iopamidol injectable solution
• Iodixanol imaging API
• Iomeprol diagnostic API
• Iohexol bulk substance for radiological pharmaceutical formulations

2. Synthesis of Specialty Agrochemical Actives

Crop protection manufacturers select this compound for integration into targeted herbicide and fungicide synthesis, especially those requiring iodinated aromatic backbones. Its structural features provide template rigidity and facilitate subsequent electrophilic substitution, contributing to shelf-stable, high-activity pesticide actives. Controlled use helps balance cost, toxicity profile, and environmental persistence.

Industry compliance standards

• FAO/WHO Specification and Evaluation for Agricultural Pesticides
• European Regulation (EC) No 1107/2009 for Plant Protection Products
• REACH registration – ECHA dossier for intermediates
• ISO 9001:2015 for production and quality documentation

Typical usage ratio

• 1:1 equivalence in the coupling reaction for final API skeleton
• Process developers may reduce to 0.85 based on target active loading

Downstream process integration

• Introduced during stagewise aromatic substitution or oxidative coupling
• Reaction carried under inert atmosphere to prevent unexpected dehalogenation
• Monitored with HPLC for conversion efficiency and side-product profile
• Downstream formulation includes microencapsulation or granulation for field use

Final product types

• Iodinated triazole fungicide active ingredients
• Diiodo-phenyl based herbicide actives
• Water-dispersible pesticide technicals
• Controlled-release agrochemical formulation granules

3. Advanced Material Science: High-Density Polymers

Manufacturers of specialty polymers employ the material as a heavy-atom monomeric additive, tuning densities and radiopacity in engineering films or medical-grade plastics. Custom polycondensation and copolymerization runs achieve targeted mechanical and imaging properties, using tightly controlled dosing and downstream process validation to ensure material homogeneity.

Industry compliance standards

• ISO 10993 for biocompatible plastics
• FDA 21 CFR 177 – Polymers for food contact (as applicable)
• RoHS Directive compliance for electronic-grade materials
• ASTM D638 for polymer tensile properties

Typical usage ratio

• 0.5–5.0 wt% as monomeric additive in batch
• Adjusted according to required density, opacity, and performance standard

Downstream process integration

• Dosed at resin kettle during prepolymer synthesis
• Combined with primary monomers, then reacted under high-shear mixing
• Post-polymerization purification removes unreacted intermediates
• Quality controlled via FTIR and DSC analysis prior to extrusion or molding

Final product types

• X-ray visible medical tubing
• High-density polymer sheets
• Protective housings for active electronic devices
• Medical imaging cassettes and markers

4. Custom Synthesis for Pharmaceutical Research Compounds

Pharmaceutical R&D organizations utilize the compound in the targeted synthesis of lead candidate molecules and reference standards featuring halogenated benzoic acid motifs. Synthetic chemists select it for library construction and structure-activity relationship studies, applying precise conditions to achieve specific substitution and avoid by-product formation during high-throughput preparation.

Industry compliance standards

• Good Laboratory Practice (GLP) OECD Guidelines
• cGMP 21 CFR Part 211 for preclinical material supply
• ICH M7 (R1) for mutagenic impurity control
• SHEQ (Safety, Health, Environment & Quality) systems

Typical usage ratio

• Applied in exact molar equivalents as per experimental design
• Pilot campaigns: 0.50–2.0 mmol per batch synthesis
• Scaled-up reference standards: 1–5 mol% loading in multi-step synthesis

Downstream process integration

• Reacted at the initial or intermediate step of benzoic acid derivative artificial routes
• Purification by preparative HPLC or flash chromatography
• Compound characterization by NMR and LC-MS prior to downstream assay
• Integrated into pharmaceutical impurity profiling or analytical method validation

Final product types

• Halogenated reference standards for QC labs
• Lead compound analogues for preclinical assessment
• API impurity markers for analytical development
• SAR intermediate libraries for medicinal chemistry

5. Organic Electronic Material Production

Producers of organic semiconductors use this compound as a precursor in synthesizing functionalized aromatic building blocks. The iodine substitution enables precise electronic tuning and energy level adjustment for performance in thin-film transistors and sensor applications. The compound enters production in carefully controlled environments, supporting the creation of new-generation organic electronics.

Industry compliance standards

• IEC 62684 for organic electronic device components
• ISO 14001 Environmental Management in chemical processing
• QAQC protocols per JEITA guidelines (Japan Electronics and Information Technology Industries Association)
• RoHS Restriction of Hazardous Substances

Typical usage ratio

• 5–20 mol% as precursor relative to primary aromatic core
• Tuned to reach target film thickness and electronic migration thresholds

Downstream process integration

• Dosed during first coupling or Suzuki–Miyaura cross-coupling reactions
• Intermediate product isolated by recrystallization or vacuum distillation
• Downstream steps include spin coating or vapor deposition for thin-film formation
• Materials characterized using UV-Vis and cyclic voltammetry

Final product types

• Thin-film transistor precursor monomers
• Organic light-emitting diode (OLED) dopant materials
• Sensing layer intermediates for biosensors
• Photoconductive film chemicals